PDCD1 and neoplasm: Anti-PD-L1 antibody inhibits the interaction between PD-L1 and PD-1 on T cells in lymph nodes and tumors and releases T cell suppression, and thus promotes the proliferation and activation leading to anti-tumor effects [3, 4].